TMCI:NASDAQ
Treace Medical Concepts, Inc
$3.88
arrow_upward
+0.26%(+0.010) 1D
$3.88
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$3.92
High
$3.95
Low
$3.82
Mkt. cap
252.33M
Avg. vol.
221.26K
Volume
144.29K
52-wk high
$7.08
52-wk low
$1.17
EPS
-$0.93
Beta
1.48
Shares outstanding
65.04M
No. of employees
450
Open
$3.92
High
$3.95
Low
$3.82
Mkt. cap
252.33M
Avg. vol.
221.26K
Volume
144.29K
52-wk high
$7.08
52-wk low
$1.17
EPS
-$0.93
Beta
1.48
Shares outstanding
65.04M
No. of employees
450
News stories
From web sources and news partners
investingLive
·
32 minutes ago
Nasdaq and S&P rebounds; Dow slips
TradingView
·
30 minutes ago
The Dow Jones Index Closes 0.07% Lower
Traders Union
·
25 minutes ago
Sherwin-Williams rebound signals improving momentum for Dow stock
Investing.com
·
29 minutes ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc